RxDoctor Payments DataLook up a doctor →

Neha Pansuria, MD

Rheumatology · Bowling Green, KYNPI 1659534071

Payments from drug & device makers

$39,129in general payments, 2019–2025

Across 1,107 payments — averaging $35.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$15K
  • Amgen$4K
  • Johnson & Johnson$4K
  • AbbVie$4K
  • Fresenius Kabi USA, LLC$2K
  • UCB, Inc.$2K
  • plus $9K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim33$15,411
Amgen(2 entities)237$3,938
Johnson & Johnson(2 entities)84$3,812
AbbVie175$3,724
Fresenius Kabi USA, LLC11$1,903
UCB, Inc.112$1,810
Mallinckrodt Hospital Products Inc.60$1,221
Novartis59$1,016
GSK51$942
AstraZeneca(2 entities)41$781
Lilly USA, LLC48$738
Pfizer40$704
E.r. Squibb & Sons, L.L.C.30$522
Radius Health, Inc.20$359
ANI Pharmaceuticals, Inc.17$243
Janssen Scientific Affairs, LLC2$217
Aurinia Pharma U.S., Inc.12$216
Organon12$176
Genentech USA, Inc.8$154
Octapharma USA, Inc.2$129
Sandoz6$123
Sanofi5$104
Cardinal Health 110 LLC1$100
Bristol Myers Squibb5$88
Regeneron Healthcare Solutions, Inc.5$86
Actelion Pharmaceuticals US, Inc.3$71
United Therapeutics Corporation4$71
Shorla Oncology Inc.2$64
Merck4$56
Celltrion USA Inc.2$51
Sanofi-aventis U.S. LLC3$48
Phadia US Inc.1$37
Kyowa Kirin, Inc.2$36
Mallinckrodt Enterprises LLC2$33
Sobi, Inc2$30
Kiniksa Pharmaceuticals International, PLC1$25
Mylan Institutional Inc.1$22
Ultragenyx Pharmaceutical Inc.1$20
Gilead1$17
Tonix Medicines, Inc.1$17
Xeris Pharmaceuticals, Inc.1$15

How this compares

$39,129 in reported general payments places this provider in the 80th percentile of 81 rheumatology providers in Kentucky.

See all rheumatology providers in Kentucky →

Medicare billing

Part B allowed, 2024
$1,257,738
Medicare patients
450
Services billed
71,254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Bowling Green

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →